Fezolinetant
CAS: 1629229-37-3
Ref. 3D-EQC22937
| 2mg | 172,00 € | ||
| 5mg | 248,00 € | ||
| 10mg | 364,00 € | ||
| 25mg | 518,00 € | ||
| 50mg | 801,00 € |
Información del producto
Fezolinetant is a drug for the treatment of menopausal symptoms. It is designed to be administered as a single dose, with the primary analysis being a questionnaire on the frequency and severity of symptoms. Fezolinetant has been shown to be efficacious in treating autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Fezolinetant also prevents cancer in mice by inhibiting the invasion and migration of tumor cells. The drug binds to receptors in cells that are involved in cancer cell growth and proliferation, which blocks the production of proteins that are essential for tumor cell division. This drug also has an efficient method of delivery, which may reduce side effects.
Propiedades químicas
Consulta técnica sobre: 3D-EQC22937 Fezolinetant
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
